 KittyBiscuits
If you look at the following presentation
you will see Eden's current and future product sales forecast. Eden states this is *Based on peak sales and a full label of all key target diseases and crops
Fair enough, but these forecasts far exceed anything Cavendish has published. How much attention are investors paying to this presentation? Does it need to be spoken to an audience so that it sinks in?
From the presentation
CURRENT (€M)
Mevalone 2.8
Cedroz 8.2 inc US
Ecovelex 3.6
to which you can hopefully, shortly, add another 14.4 with Downy Mildew and the insecticide
If you add up the current and future opportunity, I believe you get to a figure of around €130+ million
You have to assume we are pretty well advanced with Mevalone and Cedroz and their label extensions and regulatory approvals, accepting there is always more to come
The Company has said EU wide approval of Ecovelex will come this year
The Company has said Downy Mildew France, will come this year.
That just leaves the insecticide and whether the Company has submitted regulatory papers in the EU and the US. This we do not know. Might we be waiting for this prior to appointing a commercial partner(s). Who knows.
These numbers far exceed the current turnover of £4.3 million and perhaps it would be helpful to talk to a wide audience about this value opportunity, in laymans terms, such that the value proposition is understood by everyone.
Currently, Cavendish says Eden's target price is 20p. This is purely based on a 1 year forecast of regulatory approved products and anticipated sales, is it not?
The Company has said on film that in their opinion, managements opinions, the shares are already worth more than this.
Allowing for the published product sales on the Interims, available for all to see, conditional on regulatory approvals and label extensions, what is managements view of what the share price would look like, would be fairly valued at, in the event of this sales outcome.
Values are published, so it is not unreasonable for them to paint the same picture for the share price, after all, they have already commented on the same.
Some inspiration and belief for investors is perhaps one of the things needed to get the share price moving. Of course, removing a big seller (BGF) and a nice DM France regulatory approval would help and enhance this messaging. |
In this flopisode of The Sunday salad.
Sean Smith, CEO of Eden Research, delves into their innovative biopesticides and how these products are shaping sustainable agriculture along with roasty questions like why are you and your CFO paid so much and own so few company shares. Alongside these insightful interviews, the team delivers their usual roundup of the week’s biggest news stories, market movers, and the lively stock market banter you’ve come to expect. |
Breaking ground in biologicals: Major agricultural companies' brand strategies and market evolution,
"Our real point of differentiation is our passion for innovation. This combination of research-driven innovation and deep market understanding is what sets us apart from most biologicals players.″ said Matt Pickard, Head of Biologicals & Seedcare Europe at Syngenta, in an interview with AgroPages.
From 2019 to 2024, companies such as Gowan, Sumitomo Chemical, Nufarm, and Syngenta have actively expanded their biological businesses and launched new products on a global scale. Whether through technological innovation, market integration, or cross-sector cooperation and resource integration, biologicals have evolved from innovative solutions to a vital component of agricultural production.
In particular, 2023 and 2024 saw a surge in new biological brand launches by major agrochemical companies, driven by the promotion of green agriculture and environmental protection policies. This shift highlights the growing potential of biological solutions in the agricultural sector. It not only underscores the increasing importance of biologicals as a key industry development trend, but also reflects a significant rise in global market demand. In response, companies are moving beyond market segments to embrace full-chain strategies, fostering more comprehensive and diversified business growth. |
I like so many features here.Geographically spread even though U.K. has scored an own goal of huge scale.Regulation approvals have a ratchet effect. Customers - Farmers evaluate the product fully and inspect and measure full results.Nothing to do with war.Nothing to do with US Politics.Very little recognition yet.Pipeline ..., I always react badly to exhortations to patience but in effect I'm showing it.Breakeven at 8 million?Did I dream it or did someone say turnover at £100 million in 5 years. That's to say a route can be shown to such a figure. |
I like so many features here.Geographically spread even though U.K. has scored an own goal of huge scale.Regulation approvals have a ratchet effect. Customers - Farmers evaluate the product fully and inspect and measure full results.Nothing to do with war.Nothing to do with US Politics.Very little recognition yet.Pipeline ..., I always react badly to exhortations to patience but in effect I'm showing it.Breakeven at 8 million?Did I dream it or did someone say turnover at £100 million in 5 years. |
Yeah, yeah. Perhaps you should listen to the video Super posted. Some good soundbites from Sean.
Ecovelux approval is coming.
Insecticide is coming and a long list of other opportunities to work through.
Your doom and gloom outlook will soon enough be blown out of the water. |
And what crimes have I committed? List them please?
And I have told you before, I will not stand in front of a judge for anything related to Eden. When the penny finally drops, and you understand - let me know. |
I found that interview interesting . Some insights into farmer reaction and I thought I detected some strains of inevitability or SoIs lol Atb |
Kittybiscuit's feigned ignorance of his own crimes committed in RL is further exacerbation. But it is unnecessary. The extent, complexity and duration of the misconduct already merits the maximum sentence prescribed in the guidelines.
Start attending Crown Court as an observer. Prepare thyself for what awaits.
Should the offence of stupidity be added to the statute book? |
In this episode of The Sunday Roast.
Sean Smith, CEO of Eden Research, delves into their innovative biopesticides and how these products are shaping sustainable agriculture. Alongside these insightful interviews, the team delivers their usual roundup of the week’s biggest news stories, market movers, and the lively stock market banter you’ve come to expect. |
You are clutching at straws. Timbo hasn’t as far as I can see tried to persuade anyone to buy this stock. You live in a fantasy land, obsessed with trains. |
I'll raise a glass to that |
The optimistic among us might infer from the orderly procession of CSAT Viking plugs by Corteva Europe that they have sight of something that might at long last inthecoming move the share price
It could be Sunflower related.
It could be EU approval related or
It could be both.
AWGATWT |
And it is spelt Brains and branes.
All your “Evidence̶1; that Timbo Slice is using multiple IDs is based on free web based dialecticisers? You are so wrong it’s hilarious. Dug yourself so deep in the wrong hole you cannot get out. Fool. |
After posting parts 1/2/3 of the Viking CSAT story in consecutive weeks in the run up to Xmas 6th/ 12th /19th of December..
Yesterday Corteva post the 4th and final concluding part. @ 17 Jan 2025.
Corteva Europe @CortevaEUR
Here's the final chapter of the #VikingSeeds! Watch Act IV below.
United to combat birds, worms, & disease, Viking seeds laid a legacy of strength & resilience. Now with modern #SAT, their spirit lives on in modern seeds—stronger, better protected, & ready for any challenge. 🌱 |
Why fools don't use dialecticisers, I dunno. Many free ones on the web. |
More utter trash. You have NO IDEA how much Timbo Slice has invested. For the record you don’t know how much I have invested either.
And if you find it personally offensive to share the planet, suggest you step off it or at least remove yourself from the bulletin board - there is a good chap. |
Sure sure buy buy buy while the directors are too stupid to see the wonderful opportunities to accumulate within their own company.
O wait.... ROTFL!!
NEWCOMERS
The recent noise from mentally-ill, conspiracy-obsessed ramper "supersonico", who refuses to accept the 1969 moon landing was real, cutting & pasting long screeds that have no relevance to the (non-existent) prospects of this shytestock, is designed to drown out cautionary voices on this DB, i.e., those of Chrischas and especially those of ravenna23 and me.
This discussion board is a BOILER room dominated by multi-avatar PAID (and undisclosed, where lies the criminality) PROFESSIONAL RAMPERS and by multi-avatar trapped bulls, including ones like "Timbo_Slice" who are more than £1m underwater due to their incredible gullibility and stupidity.
I find it personally offensive to be compelled to share the planet with such filth - morally-repugnant degenerates. |
Register to chat with like-minded investors on our interactive forums.
Hot Features
Premium
